FBLN4 anticorps (C-Term)
Aperçu rapide pour FBLN4 anticorps (C-Term) (ABIN952327)
Antigène
Voir toutes FBLN4 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 393-422, C-Term
-
Specificité
- This antibody recognizes Fibulin-4 at C-term.
-
Réactivité croisée (Details)
- Species reactivity (tested):Human, Mouse
-
Purification
- Purified through a Protein A column followed by peptide affinity purification
-
Immunogène
- Synthetic peptide - KLH conjugated - corresponding to the C-terminal region (between 393-422aa) of human Fibulin-4
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- FBLN4 (Fibulin 4 (FBLN4))
-
Autre désignation
- Fibulin-4
-
Sujet
- EFEMP2 / Fibulin-4 has been found to contain variations of the epidermal growth factor (EGF) domain and have been implicated in functions as diverse as blood coagulation, activation of complement and determination of cell fate during development. The protein contains four EGF2 domains and six calcium-binding EGF2 domains. This protein is necessary for elastic fiber formation and connective tissue development.Synonyms: EFEMP2, EGF-containing fibulin-like extracellular matrix protein 2, FBLN4, Fibulin 4, Protein UPH1, UNQ200/PRO226
-
ID gène
- 30008
-
NCBI Accession
- NP_058634
Antigène
-